Subscribe

News
Media
Conferences
Publications
Events
CE
Resources
Subscribe

Spotlight -

Community/Retail|

Pharmacy Technician|

Opinion|Videos|May 16, 2024

Identifying Patients Who Are Candidates for Bispecifics and Referring Patients for Care

Author(s)Ryan Haumschild, PharmD, MS, MBA, Ke Ning, MD, Sarah Rockwell, PharmD, BCOP

Medical professionals share insights on treatment considerations and patient selection for bispecific antibody therapy and the process for referring patients to other institutions for care.

Episodes in this series

Video 1 - "Impact of Bispecific Antibodies on Multiple Myeloma Treatment"

EP. 1 Impact of Bispecific Antibodies on Multiple Myeloma Treatment

Video 2 - "Key Considerations in Treatment Selection for Patients With Multiple Myeloma"

EP. 2 Key Considerations in Treatment Selection for Patients With Multiple Myeloma

Video 3 - "Monitoring and Treating Adverse Events in Patients Receiving Treatment With a Bispecific Antibody"

EP. 3 Monitoring and Treating Adverse Events in Patients Receiving Treatment With a Bispecific Antibody

Video 4 - "Risk Evaluation Mitigation Strategy (REMS) Program Requirements for Bispecific Antibodies"

EP. 4 Risk Evaluation Mitigation Strategy (REMS) Program Requirements for Bispecific Antibodies

Video 5 - "The Importance of Engaging Stakeholders When Implementing Bispecific Antibodies"

EP. 5 The Importance of Engaging Stakeholders When Implementing Bispecific Antibodies

Video 6 - "Stakeholder Perspective: Step-Up Dosing for Bispecific Antibodies in Multiple Myeloma"

EP. 6 Stakeholder Perspective: Step-Up Dosing for Bispecific Antibodies in Multiple Myeloma

Video 7 - "Overcoming Challenges Related to Bispecific Antibody Adoption in Multiple Myeloma"

EP. 7 Overcoming Challenges Related to Bispecific Antibody Adoption in Multiple Myeloma

Video 8 - "Final Thoughts on Operationalization of Bispecific Antibodies for Multiple Myeloma"

EP. 8 Final Thoughts on Operationalization of Bispecific Antibodies for Multiple Myeloma

Video 09 - "Step-Up Dosing of Bispecifics in the Outpatient Setting for Patients with Multiple Myeloma"

EP. 9 Step-Up Dosing of Bispecifics in the Outpatient Setting for Patients with Multiple Myeloma

Video 09 - "Step-Up Dosing of Bispecifics in the Outpatient Setting for Patients with Multiple Myeloma"

EP. 10 Multidisciplinary Team Approach to Adverse Effect Monitoring for Bispecifics in MM

Video 11 - "Complying with REMS Training and Documentation Requirements"

EP. 11 Complying with REMS Training and Documentation Requirements

Video 12 - "Pharmacist Role in Addressing Operational Challenges of Bispecifics in MM"

EP. 12 Pharmacist Role in Addressing Operational Challenges of Bispecifics in MM

Video 12 - "Pharmacist Role in Addressing Operational Challenges of Bispecifics in MM"

EP. 13 Unmet Needs in Multiple Myeloma Care

Video 12 - "Pharmacist Role in Addressing Operational Challenges of Bispecifics in MM"

EP. 14 Treatment Sequencing and Combination Therapies for MM

Video 15 - "Key Takeaways Regarding Operationalizing Bispecific Antibodies for MM "

EP. 15 Key Takeaways Regarding Operationalizing Bispecific Antibodies for MM

Video 1 - "Impact of the Introduction of Bispecifics on the Management of Multiple Myeloma"

EP. 16 Impact of the Introduction of Bispecifics on the Management of Multiple Myeloma

Video 2 - "Key Results From the MajesTEC-1, MonumenTAL-1, and MagnetisMM-3 Trials"

EP. 17 Key Results From the MajesTEC-1, MonumenTAL-1, and MagnetisMM-3 Trials

A panel of 3 experts on multiple myeloma

EP. 18 Identifying Patients Who Are Candidates for Bispecifics and Referring Patients for Care

A panel of 3 experts on multiple myeloma

EP. 19 Collaborating with Other Care Providers to Optimize Outcomes for Patients Receiving Bispecifics

A panel of 3 experts on multiple myeloma

EP. 20 Considerations for Maintenance Therapy in the Community Oncology Setting

A panel of 3 experts on multiple myeloma

EP. 21 Team Approach to Meeting REMS Program Requirements

Video 7 - "Role of Pharmacists in Operationalizing Bispecific Antibodies"

EP. 22 Role of Pharmacists in Operationalizing Bispecific Antibodies

Video 8 - "Bispecific Antibodies Versus CAR T-Cell Therapy for RRMM in the Community Oncology Setting"

EP. 23 Bispecific Antibodies Versus CAR T-Cell Therapy for RRMM in the Community Oncology Setting

$Video 9 - "Unmet Needs in Relapsed or Refractory Multiple Myeloma"$

EP. 24 Unmet Needs in Relapsed or Refractory Multiple Myeloma

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Related Content

Flame-shaped plasma cells associated with multiple myeloma, focusing on disease awareness | Image Credit: The 2R Artificiality | stock.adobe.com

Early-Line Immunotherapy Challenges the Role of Transplant in Multiple Myeloma

ByDanielle Valletti, Assistant Editor

January 23rd 2026

Abnormal plasma cell or b-cell in multiple myeloma emitting paraprotein 3d illustration - Image credit: LASZLO | stock.adobe.com

Phase 3 MajesTEC-9 Trial Shows Survival Benefit With Teclistamab in Multiple Myeloma

ByKennedy Ferruggia, Associate Editor

January 15th 2026

Microscopic view of bone marrow slide feature are suggestive Multiple myeloma, also known as myeloma, is a type of bone marrow cancer - Image credit: Saiful52 | stock.adobe.com

New Research Explains Sex-Based Differences in Multiple Myeloma and Treatment Considerations

ByKennedy Ferruggia, Associate Editor

January 14th 2026

Multiple Myeloma. Multiple Myeloma disease blood test inmedical laboratory - Image credit: luchschenF | stock.adobe.com

Dual-Antibody Approach Advances Treatment of Extramedullary Multiple Myeloma

ByKennedy Ferruggia, Associate Editor

January 9th 2026

Pharmacists Can Advance Immunomodulatory Care in Multiple Myeloma

BySadaf Gharibi, PharmD

December 26th 2025

Latest CME

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

2.0 Credits / General Pharmacy

Empowering Patients With COPD: The Pharmacist's Role in Personalized Treatment Strategies

On-Demand Webinar

Empowering Patients With COPD: The Pharmacist's Role in Personalized Treatment Strategies

1.0 Credit / Pulmonology/Respiratory

Implementing Updated RSV Vaccination Recommendations for Older Adults: Considerations for the Pharmacist (Pharmacy Technician Credit)

On-Demand Webinar

Implementing Updated RSV Vaccination Recommendations for Older Adults: Considerations for the Pharmacist (Pharmacy Technician Credit)

0.5 Credit / Immunology

Implementing Updated RSV Vaccination Recommendations for Older Adults: Considerations for the Pharmacist (Part 3)

On-Demand Webinar

Implementing Updated RSV Vaccination Recommendations for Older Adults: Considerations for the Pharmacist (Part 3)

0.5 Credit / Immunization

Implementing Updated RSV Vaccination Recommendations for Older Adults: RSV Case Discussion (Pharmacy Technician Credit)

Case Conversation

Implementing Updated RSV Vaccination Recommendations for Older Adults: RSV Case Discussion (Pharmacy Technician Credit)

0.75 Credit / Immunization

Navigating Diabetes: A Guide to Effective Oral Treatments

Navigating Diabetes: A Guide to Effective Oral Treatments

1.0 Credits / Endocrinology, Diabetes & Metabolism

Implementing Updated RSV Vaccination Recommendations for Older Adults: Incorporating ACIP Guidelines (Part 2)

On-Demand Webinar

Implementing Updated RSV Vaccination Recommendations for Older Adults: Incorporating ACIP Guidelines (Part 2)

0.5 Credit / Immunization

Implementing Updated RSV Vaccination Recommendations for Older Adults: Incorporating ACIP Guidelines (Pharmacy Technician Credit)

On-Demand Webinar

Implementing Updated RSV Vaccination Recommendations for Older Adults: Incorporating ACIP Guidelines (Pharmacy Technician Credit)

0.5 Credit / Immunization

Implementing Updated RSV Vaccination Recommendations for Older Adults: RSV Case Discussion

Case Conversation

Implementing Updated RSV Vaccination Recommendations for Older Adults: RSV Case Discussion

0.75 Credit / Immunization

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs (Pharmacy Technician Credit)

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs (Pharmacy Technician Credit)

2.0 Credits / General Pharmacy

Understanding the Pearls and Pitfalls of Nimodipine in Aneurysmal Subarachnoid Hemorrhage: Opportunities to Improve Patient Outcomes

Webinar Registration

Understanding the Pearls and Pitfalls of Nimodipine in Aneurysmal Subarachnoid Hemorrhage: Opportunities to Improve Patient Outcomes

February 19, 2026 | March 5, 2026 | 1:00 PM & 8:00 PM ET

Implementing Updated RSV Vaccination Recommendations for Older Adults: Introduction and Disease Burden (Part 1)

On-Demand Webinar

Implementing Updated RSV Vaccination Recommendations for Older Adults: Introduction and Disease Burden (Part 1)

0.5 Credit / Immunization

Implementing Updated RSV Vaccination Recommendations for Older Adults: Introduction and Disease Burden (Pharmacy Technician Credit)

On-Demand Webinar

Implementing Updated RSV Vaccination Recommendations for Older Adults: Introduction and Disease Burden (Pharmacy Technician Credit)

0.5 Credit / Immunization

Trending on Pharmacy Times

What Pharmacists Should Know About Long COVID and Brain Health

Expert: Why Cutting Alcohol May Enhance GLP-1 Outcomes in Patients With Obesity and Diabetes Risk

Recapping 2025 ASHP Midyear: Expanding the Pharmacist’s Role in Patient Care, Technology, and Health System Resilience

Radio Frequency Identification is Revolutionizing Medication Management

Depression May Be an Early Manifestation of Neurodegenerative Changes Leading to Movement Disorders